One Step Screening Tests of Drugs of Abuse

Product Information
The increase in the recreational use of drugs of abuse in the general population and in theworkplace has prompted the need for a rapid, simple and tamper proof screening test.

One Step DOA Tests are lateral flow, one-step, qualitative, competitive inhibition immunoassays. The tests are based on the principle of the highly specific immunochemical reactions of antigens and antibodies. The test systems employ unique monoclonal antibodies to selectively identify specific drug of abuse and the corresponding metabolites in unrine samples with a high degree of sensitivity. The cut-off concentration for specific drug of abuse and its metabolites has been developed at the concentration standard set by NIDA (the National Institute on Drug Abuse) for the qualitative detection of corresponding drug in human urine.

Assay Features
Convenient & Cost Effective
Ideally suited for field and point-of-care testing
Human urine, no biohazard; Easy to collect
Room temperature storage
Long shelf life
No special laboratory equipment required

Time & Labor Saving
Ready-to-Use Reagents
Simple procedure
Total test time of 10 minutes
No special equipment required
Results are easy to interpret

Reliable Results
Highly sensitive and specificity
Product Description Quantity Catalog Number
Methadone Screen Test 40 Tests 040-35/37
Amphetamine Screen Test 40 Tests 041-35/37
Methamphetamine Screen Test 40 Tests 042-35/37
Cocaine Screen Test 40 Tests 043-35/37
THC Screen Test 40 Tests 044-35/37
Barbiturates Screen Test 40 Tests 045-35/37
Morphine Screen Test 40 Tests 046-300-35/37
Benzodiazepines Screen Test 40 Tests 047-35/37
Phencyclidine (PCP) Screen Test 40 Tests 048-35/37
Tricyclic Antidepressant Screen Test
40 Tests 049-35/37

MDMA (Ecstasy) Screen Test 40 Tests 050-35/37
Heroin Screen Test 40 Tests 051-35/37
Ketamine Screen Test 40 Tests 052-500-35/37
Buprenorphine Urine Test 40 Tests 053-35/37